Earnings Call · Q4 FY2023·2024-02-22

Q4 23EPS -21.74%·Rev n/aQ3 23EPS -4.17%·Rev n/aQ2 23EPS +14.89%·Rev n/aQ1 23EPS +50.00%·Rev n/a⚠ consensus missing

BIOMARIN PHARMACEUTICAL INC BMRN

Traci McCarty — Head of Investor Relations

Alexander Hardy — President and Chief Executive Officer

Henry Fuchs — Chief Medical Officer

Brian Mueller — Chief Financial Officer

+1.4%1d on move date+1.3% vs SPY3d+0.8%5d−4.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BMRN calls or request research access.

More BMRN calls Browse calls Request research access